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Abstract
Based on the available X-ray structures of S-adenosylhomocysteine hydrolases (SAHHs), free
energy simulations employing the MM-GBSA approach were applied to predict residues
important to the differential cofactor binding properties of human and trypanosomal SAHHs (Hs-
SAHH and Tc-SAHH), within 5 Å of the cofactor NAD+/NADH binding site. Among the 38
residues in this region, only four are different between the two enzymes. Surprisingly, the four
non-identical residues make no major contribution to differential cofactor binding between Hs-
SAHH and Tc-SAHH. On the other hand, four pairs of identical residues are shown by free energy
simulations to differentiate cofactor binding between Hs-SAHH and Tc-SAHH. Experimental
mutagenesis was performed to test these predictions for a lysine residue and a tyrosine residue of
the C-terminal extension that penetrates a partner subunit to form part of the cofactor binding site.
The K431A mutant of Tc-SAHH (TcK431A) loses its cofactor binding affinity but retains the wild
type’s tetrameric structure, while the corresponding mutant of Hs-SAHH (HsK426A) loses both
cofactor affinity and tetrameric structure (Ault-Riche et al., 1994 J Biol Chem, 269, 31472–8). The
tyrosine mutants HsY430A and TcY435A alter the NAD+ association and dissociation kinetics,
with HsY430A increasing the cofactor equilibrium dissociation constant from approximately 10
nM (Hs-SAHH) to about 800 nM while TcY435A increases the cofactor equilibrium dissociation
constant from approximately 100 nM (Tc-SAHH) to about 1 mM. Both changes result from larger
increases in off-rate combined with smaller decreases in on-rate. These investigations demonstrate
that computational free energy decomposition may be used to guide experimental studies by
suggesting sensitive sites for mutagenesis. Our finding that identical residues in two orthologous
proteins may give significantly different binding free energy contributions strongly suggests that
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Figure S1: The dependence of the concentrations of NAD+ on the rate constants for the slow-binding phase of the association of
NAD+ with the apo-forms of mutant HY430A and wild type Hs-SAHHa at 23 °C and pH 7.4. Figure S2: The dependence of the
concentrations of NAD+ on the rate constants for the slow-binding phase of the association of NAD+ with the apo-forms of mutant
TcY435A and wt Tc-SAHH (the wt Tc-SAHH data will be presented in detail elsewhere) at 23 °C and pH 7.4. Figure S3: RMSD for
the dynamic simulations of Hs-SAHH and Tc-SAHH. This material is available free of charge via the Internet at http://pubs.acs.org.
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comparative studies of homologous proteins should investigate not only different residues, but
also identical residues in these proteins.
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Mammals (1) and the protozoan parasites Trypanosoma (2), Plasmodium (3), and
Leishmania (4) all have S-adenosyl-L-homocysteine hydrolases (SAHHs), which catalyze
the hydrolysis of S-adenosyl-L-homocysteine (AdoHcy) to adenosine (Ado) and L-
homocysteine (Hcy). SAHHs are metabolically important enzymes because AdoHcy is a
feedback inhibitor of S-adenosylmethionine (AdoMet)-dependent transmethylation enzymes
that play crucial roles in regulating methylation of a variety of macromolecules and small
molecules (5). For this reason SAHHs have been considered as possible anti-parasitic drug
targets. The catalytic mechanism of SAHHs includes a complete redox cycle of a
nicotinamide cofactor (NAD+/NADH) that is tightly bound within the enzyme (1,6). The
catalytic properties of human and parasitic SAHHs are very similar. This discourages the
design of anti-parasitic drugs as substrate analogs or mechanism-based inhibitors. Our
studies of human SAHH (Hs-SAHH) and trypanosomal SAHH (Tc-SAHH), however, reveal
significant differences in the kinetics and thermodynamics of nicotinamide cofactor binding
between these two enzymes (7). This provides possible approaches to the design of
inhibitors having differential effects on Tc-SAHH compared to Hs-SAHH. Such inhibitors
may benefit patients who suffer from Chagas disease which is transmitted by the parasite
Trypanosoma cruzi (8).
Several X-ray crystallographic structures of Hs-SAHH such as 1A7A (1) and 1LI4 (6) and
Tc-SAHH (PDB: 1XBE, unpublished data of Drs. Q.-S. Li and W. Huang) are available.
Both SAHHs are homotetramers and each subunit contains a substrate-binding domain, a
cofactor (NAD+/NADH)-binding domain and a C-terminal tail which covers the cofactor-
binding site of the neighboring subunit (Figure 1). A lysine and a tyrosine located within the
C-terminal chain are very close to the NAD(H) cofactor in the X-ray structures and may
provide important contributions to cofactor binding of SAHHs. Two main conformations of
SAHH have been characterized: one is a ligand-free “open” form with the cofactor NAD+
bound (9) and the other is a “closed” form containing the cofactor NADH and oxidized
substrate (DHCeA (1) or NepA (6)). The atomic-level mechanism of the differential
nicotinamide cofactor binding properties of Hs-SAHH and Tc-SAHH, however, is not yet
clear (7).
To analyze microscopic differences between NAD binding to Hs-SAHH and Tc-SAHH, we
have estimated cofactor binding free energy decompositions based on the MM-GBSA
approach (10). The free energy decomposition estimations permit the prediction of residues
which significantly contribute the most to cofactor binding. In the present study,
experimental mutagenesis was then performed to test computational predictions for two
pairs of conserved residues: a lysine and a tyrosine in the C-terminal tail in both enzymes.
For a majority of these mutants, the experimental results were qualitatively consistent with
the computational predictions, confirming the utility of MM-GBSA free energy estimations
for identification of functionally important protein sites.
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The starting crystallographic structures of Hs-SAHH and Tc-SAHH were downloaded from
the Protein Data Bank (PDB) (entries 1A7A and 1XBE, respectively). Calculations for
another crystal structure of Hs-SAHH (PDB code: 1IL4) yielded very similar results. Thus,
only the data for the 1A7A structure are shown in this study. The 1A7A structure was
originally solved by incorporating selenium atoms (SE) in place of the sulfurs in Met
residues. Assuming that this does not influence structure, we replaced Se atoms with S
atoms and renamed the residues from MSE to MET. The simulation system was set up using
the Xleap module of the Amber 7 software package (http://ambermd.org/). The SAHH
homotetramer is a “dimer of dimers”, with one of the dimers formed by subunits A and B,
and the other formed by subunits C and D. In brief, the protein (the AB dimer - each subunit
bound with one NADH and one inhibitor) was solvated using a periodic truncated octahedral
box of 29,419 water molecules, as described by the TIP3P model (11), and extended to a
distance of 10 Å from any solute atom. The system was then neutralized by 16 sodium
cations initially placed around the protein using a Coulombic potential on a grid. All
minimization and molecular dynamics (MD) were performed with the Amber 7 suite of
programs. The ff99 force field was used for proteins and NADH cofactor throughout the
energy minimization and MD simulations. The starting geometry of ligands was taken from
the protein PDB files. The input files for ligand MD simulations were prepared with
antechAmber program in Amber 7, which uses General Amber Force Field (GAFF). Partial
charges on the ligand atoms were calculated with the AM1-BCC method available in
antechAmber (12).
Energy Minimization—The energy minimization was performed using the sander module
in the Amber 7 suite of programs with the particle - mesh Ewald method for inclusion of
long-range electrostatic interactions (13). We used two stages of energy minimization. In the
first stage, only water molecules were minimized while the protein was fixed. The second
stage minimized the entire system. Each stage was conducted with 500 cycles of steepest
descent followed by 4500 conjugate steps of gradient minimization. The non-bonded cutoff
was set to 12.0 Å.
Molecular Dynamics Simulations—The equilibration process was carried out in two
stages following the protocol suggested in the Amber 7 manual. In the first stage, the system
was heated gradually from a low temperature of 100 K to 300 K over 10 picoseconds (ps)
simulation time with a time step of 2 femtoseconds (fs). A cutoff distance of 12 Å was used
for the non-bonded interaction. The SHAKE algorithm was used to constrain the bonds
involving hydrogen atoms and the force evaluations for these bonds were omitted (14). A
periodic boundary with a constant volume and without pressure control was used. Then a
second 10 ps equilibration was continued under a constant pressure and a constant
temperature with isotropic position scaling to adjust the density of water to experimental
values. After that, the entire system was equilibrated for 100 ps under a constant temperature
of 300 K and a constant pressure of 1 bar. The SHAKE algorithm and 2 fs time steps were
employed through all MD stages.
A 500 ps production run was performed with the same protocol used in the final stage of
equilibration. After the simulation was completed, the ptraj module in Amber 7 was used to
re-image the whole trajectory (including all equilibration and production runs), and to
remove the waters and Na+ from the trajectory file, and to calculate the root-mean-square
deviations (rmsd) of backbone atoms from the starting structure over the entire course. Fifty
snapshots were taken at 2-ps intervals from the section of the MD trajectory where the rmsd
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reached a plateau and were used for further analysis. These sections corresponded to an
rmsd of about 1.5 Å for Hs-SAHH and an rmsd of about 1.3 Å for Tc-SAHH.
Calculation of energy decomposition by MM-GBSA—The residue-level free energy
contributions to the cofactor binding were estimated using the MM-GBPA approach
implemented in the mm_pbsa.pl script available in the Amber package. MM-GBSA is a
post-processing method that can be used to evaluate free energy contributions at the residue
level of binding of molecules in solution (15). It combines the molecular mechanical
energies with the implicit solvent approaches. The molecular mechanical energies,
representing internal energy, Van der Waals and electrostatic interactions, are calculated
using the sander program in the AMBER package. The generalized Born (GB) model
implemented in sander is used to estimate the electrostatic contribution to the solvation free
energy, and the solvent-accessible surface area dependent term is used to determine the
hydrophobic contribution to the solvation energy. The conformational entropies could be
estimated using normal mode analysis but were not considered because of computer
resource limitations. The entropic term is probably much smaller than the others and may be
neglected in comparative studies of very similar systems (10). In this study, we used the
single trajectory protocol (10) based on the assumption that the snapshots of the protein and
cofactor taken from the complex trajectory are similar to those that would emerge from
separate trajectories of protein and cofactor, or that the differences in the snapshots of single
and separate trajectories are consistent between Hs-SAHH and Tc-SAHH. Both
circumstances are considered acceptable because we were interested in the relative
difference of the free energy contributions in these residues in Tc-SAHH and Hs-SAHH.
The simulated complex was a dimer bound with two cofactors and inhibitors [closed-form
Hs-SAHH with DHCeA (pdb code: 1A7A) and closed-form Tc-SAHH with NepA (pdb
code: 1XBE)]. In the analysis of individual residue contributions to ΔG, we only considered
the 38 residues within 5 Å of the NAD(H) binding site in Hs-SAHH as well as Tc-SAHH.
We calculated the difference of free energy contributions of all of these residues.
Experimental procedures
Construction of the mutants of Hs-SAHH and Tc-SAHH—The wild type genes of
Hs-SAHH and Tc-SAHH were each inserted into its own copy of the pPROK-1 vector
(Clonetech, CA). Three alanine mutants (HsY430A, TcK431A, TcY435A) were prepared by
the site-directed mutagenesis PCR. The primer sequences are listed below:
HsY430A: 5′-- CAAGCCGGATCACGCCCGCTACTGAGA -- 3′
5′ -- TCTCAGTAGCGGGCGTGATCCGGCTTG -- 3′
TcK431A: 5′ – ACGGCCCATTCGCGCCGGACCACTACC – 3′
5′ – GGTAGTGGTCCGGCGCGAATGGGCCGT – 3′
TcY435A: 5′ – AAGCCGGACCACGCCCGCTACTAATCG – 3′
5′ – CGATTAGTAGCGGGCGTGGTCCGGCTT – 3′
The amplification reactions of HsY430A, TcK431A and TcY435A were performed in a
volume of 50 μL containing 20 ng template, 25 pmol of 5′ and 3′ primers, 12.5 nmol of each
deoxynucleoside triphosphate, 3 U native Pfu DNA polymerase (Stratagene), 6 μL 10x Pfu
buffer and 2.5 μL DMSO. The steps of the PCR program were set up as follows: 1) 92 °C
for 4 min; 2) 25 cycles of 92 °C for 30 sec, 52 °C for 30 sec and 68 °C for 20 mins; 3) 68 °C
for 10 min; 4) hold at 4 °C. The PCR products of HsY430A and TcK431A were purified
with a Qiagen PCR purification kit, while the PCR product of TcY435A contains two
fragments of different sizes. The correct-size band (large size) was cut and collected from a
1 % DNA gel (low melting point) and then the PCR product was recycled by a Qiagen gel
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extraction kit. These three purified PCR products were digested by DpnI (Biolab) and
transformed into E. coli competent cell stain JM109 (Sigma). The purified mutant genes
were confirmed by DNA sequencing.
Purification of the mutants of Hs-SAHH and Tc-SAHH—The procedures of
overexpression (7), purification (7) and cell-free extract preparation (16) of the Hs-SAHH
and Tc-SAHH mutants were similar to those previously described for the wild type SAHHs
with modifications as follows. The cell-free extracts were passed through a FPLC system
(Amersham Biosciences) including four different columns, namely a Q-sepharose Fast Flow
column (26/10), Hiload Phenyl-sepharose column (26/10), Hiload Superdex 200 (16/60) and
MonoQ (10/10) column. Buffer A is 25 mM Tris-HCl buffer pH 7.4, 1 mM EDTA, 40 μM
NAD+. Buffer B is 80 mM Tris-HCl buffer pH 7.4, 1 mM EDTA, 1 M NaCl and 40 μM
NAD+. After the Q-sepharose Fast Flow column (26/10), mutant proteins were identified by
SDS-PAGE. The mutant TcK431A was purified employing only by Q-sepharose Fast Flow
column (26/10) and Hiload Superdex 200 (16/60) columns.
Hydrolytic activity assay—The procedures for measuring SAHH activity in the
hydrolytic direction were as described in previous work (16). The generated Ado was
quickly removed by Ado deaminase to drive completion of the hydrolytic reaction. The rate
of Hcy production was coupled with the formation of TNB2− from DTNB. TNB2− is
intensely yellow and was determined at the absorption wavelength of 412 nm by UV
spectroscopy.
Reconstitution of the NAD+ form and NADH form of Hs-SAHH and Tc-SAHH
mutants—Preparation of the apo forms of Hs-SAHH and Tc-SAHH mutants and
reconstitution of the NAD+ and the NADH forms of Hs-SAHH and Tc-SAHH mutants
followed the same procedures described previously for wild type SAHHs (16). Apo forms of
SAHH mutants were prepared by using 80% (v/v) acid ammonium sulfate with 2–5 mM
DTT to precipitate purified mutants three times (pH 2.92, pH 3.12 and pH 7.2). The proteins
collected by centrifugation were dissolved in 50 mM phosphate buffer at pH 7.2 containing
1 mM EDTA. 1 mM NAD+ or NADH were incubated with 10 mg/mL apo forms of the
SAHH mutants for 12 h at 4 °C. The reconstituted NAD+ (or NADH) form of the mutants
was then purified by a Hiload Superdex 200 (16/60) column (Amersham Sciences).
Determination of contents of NADH in the isolated Hs-SAHH and Tc-SAHH
mutants—The mutant proteins (395 μg in 90 μL of 50 mM phosphate buffer, pH 7.2, 1
mM EDTA) were mixed with 10 μL of 1 M Na2CO3/NaHCO3, pH 10.7. A volume of 700
μL of 95 % ethanol was then added to denature proteins and release NADH into solution.
After centrifugation at 13,400 rpm for 10 min to remove precipitated proteins, the
fluorescence intensity of NADH was measured by a photon technologies QM-3 scanning
luminescence spectrophotometer. The excitation wavelength was 340 nm and the emission
wavelength was 450 nm. NADH standards were prepared ranging from 0.1–10 μM and were
used to determine NADH content. The NADH content of SAHH inactivated by NepA was
used as a control (100 % NAD+ reduced to NADH).
Determination of contents of NAD+ in Hs -SAHH and Tc-SAHH mutants—The
mutant proteins (395 μg in 80 μL of 50 mM KPB, pH 7.2, 1 mM EDTA) were denatured by
addition of 2 μL of 5 M HClO4. Samples were centrifuged at 13,400 rpm for 10 mins at 4 °C
to remove precipitated proteins. Supernatant was injected into a reversed-phase C18 column
(Vydac 218TP54, 300 Å, 5 μm, 4.5×250 mm) to measure the concentration of NAD+ at 258
nm. The NAD+ standard curve was made for the range of 1–200 μM. NAD+ was eluted
from the HPLC column at ~ 5.9 min by a gradient of 2–10 % mobile phase B over 20 min
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with a flow rate of 1 mL/min. Mobile phase A contained 10 mM 1-heptanesulfatic acid, 50




Single-residue contributions to the free energy of NADH binding to Hs-SAHH
and Tc-SAHH—Hs-SAHH and Tc-SAHH share about 70 % identity of their amino-acid
sequences. In superimposed structures of Hs-SAHH and Tc-SAHH, with the superposition
centered on the center of mass of the cofactor NADH, there are 38 protein residues within a
5-Å thick shell around the cofactor. To identify protein residues with the largest
contributions to differential cofactor binding of Hs-SAHH and Tc-SAHH, contributions to
the NADH binding free energy from every residue within 5 Å of the cofactor binding site
were calculated and the results are listed in Table 1. Thirty-four of these 38 residues (89 %)
are identical in Hs-SAHH and Tc-SAHH, while four pairs are different. In most cases the
individual residue contributions to cofactor binding are very similar in the two proteins.
Interestingly, four pairs of identical residues (HsAaaTc: 191ASN193; 243GLU242;
426LYS431; 430TYR435), which are shown in red in Table 1, make significantly different
free-energy contributions to the binding of NADH to Hs-SAHH and Tc-SAHH.
Experimental Results
Y430 in the C-terminal extension of Hs-SAHH may slightly influence binding
of NAD+ and NADH to apo-Hs-SAHH—The mutant HsY430A is a purified protein of
the correct molecular mass (190 kD) and possesses an intact tetrameric structure (as
evaluated by size exclusion chromatography). The enzyme is isolated from the expression
system with 30 ± 5 % active-site occupancy by NAD+ (HPLC) and 86 ± 5% active-site
occupancy by NADH (fluorescence). Denaturation of the isolated enzyme yielded 3.1 ±
0.1% adenosine and 81 ± 1% adenine. Reconstitution of apo-HsY430A with NAD+ yielded
protein with 79 ± 1% occupancy (HPLC) and 70 ± 1% catalytic activity. Reconstitution of
apo-HsY430A with NADH yielded protein with 94 ± 1% occupancy (fluorescence).
K431 in the C-terminal extension of Tc-SAHH is required for the binding of
NAD+ and NADH to apo-Tc-SAHH—The purified mutant TcK431A was also of the
correct molecular mass (194 kDa) and possesses an intact tetrameric structure (size
exclusion chromatography). The enzyme is isolated from the expression system with no
NAD+ present (detection limit 0.1 % active-site occupancy) and little NADH occupancy
(1.30 ± 0.03 % active-site occupancy by fluorescence). Attempts at reconstitution with
cofactor of apo-TcK431A yielded no detectable occupancy by either NAD+ or NADH.
Y435 in the C-terminal extension of Tc-SAHH is required for tight binding of
NAD+ and NADH to apo-Tc-SAHH—The mutant TcY435A was again of the correct
molecular mass (194 kDa) and possesses an intact tetrameric structure (size exclusion
chromatography). The enzyme is isolated from the expression system with 18 ± 1% active-
site occupancy by NAD+ (HPLC) and 90 ± 1% active-site occupancy by NADH
(fluorescence). Denaturation of the isolated enzyme yielded 24 ± 1% adenosine and 65 ± 1%
adenine. Attempted reconstitution of apo-TcY435A with NAD+ or NADH yielded protein
with no detectable occupancy.
Rate constants for dissociation of NAD+ from mutant SAHHs HsY430A and
TcY435A are 20-fold and 255-fold larger, respectively, than those for the
corresponding wild-type enzymes—Cofactor dissociated from the mutant enzymes in
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a simple first-order relaxation process (as previously observed in other cases [(7,9,17) and
unpublished data of Q.-S. Li] in which the enzymic activity proceeded from full activity to
zero activity). Mutant HsY430A released cofactor at 30 °C, pH 7.4, with koff = 4.2 ± 0.1 ×
10−4 s−1 while the wild-type enzyme Hs-SAHH released cofactor with koff = 1.9 ± 0.3 ×
10−5 s−1. The mutation therefore increases the dissociation rate constant by a factor of about
20. Mutant TcY435A released cofactor at 24 °C, pH 7.4, with koff = 2.8 ± 0.2 × 10−2 s−1
while the wild-type enzyme Tc-SAHH released cofactor with koff = 1.1 ± 0.2 × 10−4 s−1.
The mutation therefore increases the dissociation rate constant by a factor of about 255. The
values of these rate constants are included with other data in Table 2.
Association kinetics of NAD+ with mutant SAHHs HsY430A and TcY435A—
These mutant enzymes exhibited (Supporting information) association time courses like
those seen with the other SAHHs [(7, 9, 17) and unpublished data of Q.-S. Li]: fast binding
occurred within the dead-time of the experiment giving rise to an initial enzyme activity Ao;
slow binding ensued with an apparent first-order rate constant kapp and combined with Ao to
give a final activity Af. Each of these three parameters is a function of [NAD+]. The
expected dependences on the basis of a model to be described in the Discussion Section are




Here At is the total enzyme activity at saturating NAD+ concentrations after completion of
both phases of binding. Figure 2 shows (a) the dependences on [NAD+] of the fraction of
fast binding Ao/At, the fraction of slow binding (Af − Ao)/At, and the fraction of total
binding Af/At; (b) the dependence of kapp on [NAD+] for the mutants HsY430A and
TcY435A. The curves in Fig. 2 represent least-squares best fits of eqs 1 to the data, with
parameters Ko, n, Kf, ka, and Ka as given in Table 2.
Discussion
Computed free-energy contributions of individual residues to the cofactor affinities of Hs-
SAHH and Tc-SAHH identify four conserved residues as the locus of differential cofactor
affinities
The 38 residues within 5 Å of the NAD(H) binding site which may form strong interactions
with cofactor NAD(H) were chosen for this study. The structures of Hs-SAHH and Tc-
SAHH were overlaid and 34 out of the 38 residue pairs were found to be identical. The four
pairs of non-identical residues were HsA219, TcC218; HsI244, TcV243; HsC278, TcN277;
HsL417, TcI422, shown in boldface font in Table 1. None of these four non-identical
residues, however, makes a significant free-energy contribution to the differential in the free
energy of cofactor binding between Hs-SAHH and Tc-SAHH (Table 1). In fact, it is four
pairs of identical residues (shown in red in Table 1: Hs/Tc N191/190; E243/242; K426/431;
Y430/435) that show the most significant differential free-energy contributions (from about
3.4 to 7.4 kcal/mol) to the cofactor binding of Hs-SAHH and Tc-SAHH.
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In deciding which cases to address experimentally, we took note of the facts that Turner et
al. (18) had identified HsK426 and HsY430 as of special interest because they are “involved
in interactions with the NAD bound predominantly to the other monomer,” an unusual
feature of cofactor binding in SAHHs, and that Ault-Riché et al (19) had prepared the
mutant HsK426A and found it to be devoid of cofactor affinity and catalytic activity. We
therefore decided to concentrate on HsK426, HsY430, and the corresponding residues of Ts-
SAHH, TcK431 and TcY435.
Y430 in the C-terminal extension of Hs-SAHH only slightly influences binding of NAD+ and
NADH to apo-Hs-SAHH
The mutant HsY430A continues to bind NAD+ and NADH sufficiently strongly that the
enzyme passes through the purification procedure from the expression system with
essentially full occupancy of the cofactor sites (116 ± 7%). A preponderance of the cofactor
sites was occupied by NADH (86 ± 5%). Denaturation resulted in release of a small amount
of adenine (ca. 3%) and a larger amount (81 ± 1%) of adenosine. One possible explanation
of these observations is that at least part of the NADH arose by oxidation of adenosine in the
active site to 3′-ketoadenosine, which can decompose to generate adenine, the fragments
then remaining in the active site in the “closed” conformation (1,6) of the enzyme. The
isolated enzyme could be converted to the apo-enzyme and reconstituted to around 79%
occupancy by NAD+, with the reconstituted enzyme exhibiting around 70% of the activity
of wild-type enzyme which has full occupancy of NAD+. The HsY430A mutation thus has
no large effect on the effective affinity of the enzyme for NAD+ or NADH, and little or no
effect on the enzyme activity.
K431 in the C-terminal extension of Tc-SAHH is required for the binding of NAD+ and
NADH to apo-Tc-SAHH
The mutant TcK431A is the equivalent of the mutant HsK426A, prepared in previous work
(17) and shown to have lost both cofactor affinity and tetrameric structure. TcK431A
maintains its tetrameric structure but is isolated from the expression system without cofactor
and cannot be reconstituted under normal conditions with either NAD+ or NADH. Thus, as
with Hs-SAHH, this lysine residue is critical for the cofactor affinity (it is thought to form
hydrogen bonds to the the 2′- or 3′-OH group of nicotinamide-bearing ribose ring) (1). It is
striking that the mutation causes the loss of tetrameric structure in Hs-SAHH but not in Tc-
SAHH. Previous comparisons [(7,17) and unpublished data of Dr. Li] of Hs-SAHH, Tc-
SAHH, and their mutants have suggested that Hs-SAHH possesses a structure more robust
with respect to mutation, typically showing smaller changes in its properties upon mutation
than does Tc-SAHH. The quaternary structure would seem to be an exception to this rule.
Y435 in the C-terminal extension of Tc-SAHH is required for tight binding of NAD+ and
NADH to apo-Tc-SAHH
The mutant TcY435A is the equivalent of HsY430A described above. Like HsY430A, the
Tc-mutant is isolated with high occupancy of cofactor (mostly NADH) and releases a
mixture of adenosine and adenine upon denaturation. Unlike HsY430A, the apo-form of the
Tc-mutant no longer exhibits sufficient effective affinity for cofactor to permit
reconstitution. The kinetic experiments reported here were conducted with enzyme as
isolated from the expression system.
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Rate constants for dissociation of NAD+ from mutant SAHHs HsY430A and TcY435A are
20-fold and 255-fold larger, respectively, than those for the corresponding wild-type
enzymes
The experimental results show that loss of the tyrosine in both enzymes increases the
dissociation rate constant for NAD+, but not for NADH. The increase is an order of
magnitude larger for the human than for the Tc-enzyme. This is consistent with the
systematic observation cited above [(7,9,17) and unpublished data of Q.-S. Li] that the
human enzyme is less susceptible to mutational changes in its properties than the
trypanosomal enzyme.
Association kinetics of NAD+ with mutant SAHHs HsY430A and TcY435A
Cofactor combination with these mutant enzymes followed a model previously observed
with Hs-SAHH, Tc-SAHH and various mutants of both [(7,9,17) and unpublished data of
Dr. Li]. The elements of this model are the following:
1. The apo-enzyme possesses two equally numbered classes of active sites.
2. Half of the sites are capable of binding cofactor rapidly (during the dead time of the
experiment), with a relatively low affinity, and generating the full activity of these
sites. This phenomenon accounts for the fast-binding activity Ao observed at time
zero from sites with cofactor-dissociation constant Ko and Hill coefficient n.
3. Half of the apo-enzyme sites (slow-binding sites) are capable of binding cofactor
rapidly, with a relatively high affinity (dissociation constant Ka), but initially
generating no enzymic activity. These events initiate a time-dependent
reorganization with rate constant ka in which the slow-binding sites acquire full
enzymic activity and all sites acquire a common cofactor-dissociation constant Kf,
the final activity being Af.
This model generates eqs 1 above, which were fit to the data as shown in Fig. 2, producing
the values of Ko, Ka, Kf, ka, and n given in Table 2. Table 2 also gives these values for Hs-
SAHH and Tc-SAHH as determined previously (7). Finally Table 2 presents values of the
“on” rate constant for NAD+, estimated as described in the Materials and Methods section
by two different methods, and the “off” rate constant for NAD+, obtained as described
above. Together these allow the calculation of the equilibrium constant Kd for NAD+.
Comparison of the association kinetics for the wild-type enzymes Hs-SAHH and Tc-SAHH
show no dramatic differences. The value of koff is about 5-fold larger for Tc-SAHH and
values for kon smaller by 2 or 3-fold; the result is a dissociation constant 10 or 20-fold
larger.
The mutant HsY430A has lower affinity for the fast-binding sites and a smaller
reorganization rate constant ka than Hs-SAHH, perhaps suggesting that some of the binding
and reorganization events involve Y430 or its neighbors. The mutant off-rate is over 20-fold
larger and the on-rate 4-fold slower than for Hs-SAHH, resulting in a dissociation constant
larger by about 100-fold.
The mutant TcY435A exhibits far more dramatic effects: the constants Ko, Ka, and Kf have
all risen from the Tc-SAHH values of approximately micromolar values to around
millimolar values, indicating that these affinities are significantly reduced by the removal of
the tyrosine residue. The rate constant for reorganization is unaffected but the off-rate of
cofactor is increased by nearly 1000-fold, while the on-rates are smaller by about 100-fold.
The result is cofactor binding with a millimolar dissociation constant in the mutant to a sub-
micromolar dissociation constant for the wild-type Tc-SAHH.
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This relationship is similar to that for the HsY430A mutation and for the Tc-SAHH/Hs-
SAHH comparison: a somewhat smaller decrease in on-rate combines with a larger increase
in off-rate to generate a weaker cofactor binding in the mutant enzyme compared to the
wild-type enzyme or in Tc-SAHH compared to Hs-SAHH.
Why do identical residues in two orthologous proteins give significantly
different contributions to the binding free energy?
In the present study, the predicted differential contributions to the binding free energies of
two pairs of identical amino acid residues have been largely confirmed by the experimental
results, despite the intuitive notion that identical residues in two orthologous proteins should
give similar binding free energy contributions. To investigate the reasons for this result, we
examined the simulation snapshots of Tc-SAHH and Hs-SAHH. The C-loops of Hs-SAHH
(in red) and Tc-SAHH (in blue) were superimposed and displayed, along with nearby
NADHs, in Figure 3. We calculated the averages and standard errors of the distances of
oxygen atoms of Lys or nitrogen atoms of Tyr to oxygen atoms of pyrophosphates between
Tc-SAHH and Hs-SAHH. It is clear that these distances in Tc-SAHH and Hs-SAHH are
different. Consequently the strength of the hydrogen bonds formed between Tyr or Lys and
NADH is significantly different in these two enzymes. We rationalize that the distance
difference between these C-loops and NADHs can be caused by the slightly different shape
of the cofactor binding pocket or the overall conformation of the proteins, which originates
from the sequence difference between these two proteins. Thus “identical” residues in two
non-identical sequences should be regarded as only approximately identical.
Conclusion
Computational approaches and crystallographic structures of SAHHs suggest that a lysine
residue and a tyrosine residue in a C-terminal extension of each subunit that forms part of
the NAD+/NADH binding site in a partner subunit might be critical for full cofactor affinity.
Earlier work (19) showed that the mutation HsK426A of the human enzyme Hs-SAHH
eliminated both cofactor affinity and the terameric structure of the enzyme. Here we show
that the corresponding mutation TcK431A in the trypanosomal enzyme Tc-SAHH greatly
reduces cofactor affinity but leaves the tetrameric structure intact, a rare example in which
the trypanosomal enzyme appears more robust to mutational damage than the human
enzyme. Residue HsY430 modulates the association-dissociation kinetics significantly in the
case of Hs-SAHH, generating through its mutation to Ala a decreased cofactor affinity by
just under 100-fold. The corresponding mutation TcY435A decreased cofactor affinity by
approximately 100,000-fold. Both effects arise from a larger increase in the off-rate of the
cofactor, combined with a smaller decrease in on-rate. It should be noted that the values of
Kf, the apparent dissociation constants of NAD+ corresponding to a period immediately
after mixing of apoenzymes with cofactor, are on the order of micromolar for both Hs-
SAHH and Tc-SAHH (Table 2). Binding at this level persists or strengthens by about 10-
fold for Tc-SAHH but becomes stronger by about 100-fold for Hs-SAHH over a period of
some hours, eventually reaching roughly nanomolar values of the dissociation constant (as
reflected in the values of koff/(ka/Ka ) in Table 2). This phenomenon was observed
previously (7) but remains unexplained.
These investigations demonstrate that free energy decomposition may be used to guide
experimental studies by suggesting sensitive sites for mutagenesis. Our finding that identical
residues in two orthologous proteins may give significantly different binding free energy
contributions strongly suggests that comparative studies of homologous proteins should
investigate not only different residues, but also identical residues in these proteins.
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Abbreviations





FPLC fast protein liquid chromatography
Hcy L-homocysteine
HPLC high performance liquid chromatography
Hs-SAHH SAHH from Homo sapiens (human placenta)
NAD+ β-nicotinamide adenine dinucleotide
NADH β-nicotinamide adenine dinucleotide, reduced form
P. falciparum Plasmodium falciparum
SAHH S-adenosyl-L-homocysteine hydrolase, EC 3.1.1.1
Tc-SAHH SAHH from Trypanosoma cruzi
T. cruzi Trypanosoma cruzi
rmsd root-mean-square deviations
MM-GBSA Molecular Mechanics-Generalized Born Surface Area
DHCeA (1′R, 2′S, 3′R)-9-(2′, 3′-dihydroxycyclopent-4′-enyl)adenine
NepA neplanocin A
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The “dimer” structure of SAHHs that forms a part of the overall tetrameric enzyme structure
(1). The monomers are shown in blue and green, with cofactor ligands in gold ball-and-stick
representations and a substrate-analog ligand in a turquoise ball-and-stick representation.
The C-terminal extension of each monomer, containing helix 18, can be seen penetrating
into the partner monomer to form part of the cofactor binding site (top left, in green; bottom
right, in blue). K426 (in red ball-and-stick) and Y430 (in black ball-and-stick) (Hs-SAHH)
are located in the final coil between helix 18 and the C-terminus.
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Above: The fractions of fast binding, slow binding, and total binding of NAD+ to the mutant
enzyme HsY430A (left) and the value of the slow-binding rate constant kapp (right), both as
a function of [NAD+]. Below: The fractions of fast binding, slow binding, and total binding
of NAD+ to the mutant enzyme TcY435A (left) and the value of the slow-binding rate
constant kapp (right), both as a function of [NAD+]. The curves are drawn from eqs 1 with
the least-squares best-fit parameters given in Table 2. Note that the concentration scales for
HsY430A are below 300 μM while those for TcY435A go up to 5 mM.
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Superimposed C-loops of Hs-SAHH (in red) and Tc-SAHH (in blue) and nearby NADHs.
The averages and standard errors of the distances of oxygen atoms of Lys and nitrogen
atoms of Tyr to oxygen atoms of pyrophosphates are shown in either red (for Tc-SAHH) or
blue (for Hs-SAHH).
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